Imaging
FDA grants 510(k) clearance to amyloid imaging tool
The FDA has granted 510(k) clearance to a Centiloid scaling apparatus software for positron emission tomography-based amyloid imaging to evaluate individuals for Alzheimer’s disease-related pathology.
BLOG: Objectively assess the patellofemoral joint with 3D imaging
New awareness of 3D imaging of the patellofemoral joint is adding further objectivity to our analysis.
Diagnostic Testing and Imaging Studies
Imaging device tracks skin improvement following prebiotic treatment in skin of color
A new imaging device effectively monitored skin texture changes in patients with skin of color with atopic dermatitis and xerosis following a prebiotic skincare regimen, according to a study.
Lantheus acquires Meilleur, including global rights to PET imaging agent for Alzheimer’s
Lantheus Holdings Inc. has announced the acquisition of Meilleur Technologies Inc., which includes the transfer of its rights to an amyloid-beta positron emission tomography imaging agent.
Forefoot ‘can be omitted’ when using ultrasound to predict rheumatoid arthritis
Forefoot ultrasound adds little value when attempting to predict rheumatoid arthritis in patients with clinically suspect arthralgia, as positive findings there are “rare” without accompanying inflammation in the hands, according to data.
Synopsis and Assessment of the 2015 Gout Classification Criteria
Diagnosis of Gout and Use of Laboratory and Imaging
Imaging
Q&A: New pediatric guidance for advanced imaging in ED
New guidance from the AAP and other groups advises providers to weigh the benefits and risks of performing advanced imaging on children in the ED.